Skip to main content

About your Search

20130124
20130201
STATION
CNBC 2
LANGUAGE
Search Results 0 to 1 of about 2
CNBC
Jan 23, 2013 7:00pm EST
about revenue, cuts, whatever it may be if president obama floats chain cpi like he did before, that's reindexing down -- >> he won't do it. >> he did it before. >> he did it for ten minutes and then his budget director and chief of staff, jack lew, who is going to the treasury department, who is not qualified to that position just backed out. he caved in to the left wing of the democratic party in the senate. i think that's a good divisive issue for republicans. that's how they divide democrats. we have a couple of them, on guns and entitlements. i don't know what got into boehner today. he's too pessimistic. >> i think he's a realist. he famously told harry reid to go and do something that we can't say on the air during the fiscal cliff talks. so, no, the speaker is in high spirits and heeps got a -- he's got a lot more support today -- >> where is this annihilation talk today? >> larry, usually when you no longer have the prospect of a reelection, you become less partisan. he's just trying to nullify his base and check the boxes of those who helped him cross the finish line pip wo
CNBC
Jan 29, 2013 6:00am EST
of money to develop them. but then again, we all have this problem with keeping health care costs down and obama care wants generic competition for biologics. what's the right road to take there? >> you know, joe, we've been in this industry for over 135 years. for us, we've taken a focus and we pursue both small molecule as well as bioological routes to address some of the most oppressing diseases out there. if you take alzheimer's, we have the biologic but we have a base inhibitor in phase two -- >> would you pay a lobbyist, would you get lobbyists for eli lilly to try to make it that you don't have to have generic competition for biologics, is that something eli lilly would do, or do you go along with it? >> well, remember, in the affordable care act we did get an extension in terms of data protection, as we should be, to at least 12 years. we believe that's very important for us to have a reasonable period to generate return on investment that we make in r&d. we still are the industry that invests the most in r&d, research and development, in this country. we from a policy standpoi
Search Results 0 to 1 of about 2